Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.

Palacios S, Currie H, Mikkola TS, Dragon E.

Maturitas. 2015 Apr;80(4):435-40. doi: 10.1016/j.maturitas.2015.01.003. Epub 2015 Jan 24. Review.

PMID:
25684082
2.

Use of SERMs for treatment in postmenopausal women.

Pinkerton JV, Thomas S.

J Steroid Biochem Mol Biol. 2014 Jul;142:142-54. doi: 10.1016/j.jsbmb.2013.12.011. Epub 2013 Dec 25. Review.

PMID:
24373794
3.

Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.

Pinkerton JV, Stovall DW.

Expert Opin Investig Drugs. 2010 Dec;19(12):1613-21. doi: 10.1517/13543784.2010.532487. Epub 2010 Nov 13. Review.

PMID:
21073353
4.

Venous thrombosis and conjugated equine estrogen in women without a uterus.

Curb JD, Prentice RL, Bray PF, Langer RD, Van Horn L, Barnabei VM, Bloch MJ, Cyr MG, Gass M, Lepine L, Rodabough RJ, Sidney S, Uwaifo GI, Rosendaal FR.

Arch Intern Med. 2006 Apr 10;166(7):772-80.

PMID:
16606815
5.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators.

JAMA. 2002 Jul 17;288(3):321-33.

PMID:
12117397
6.

Amenorrhea and endometrial atrophy.

Fribourg S.

Obstet Gynecol. 1985 Dec;66(6):836-7. No abstract available.

PMID:
2999662

Supplemental Content

Loading ...
Support Center